NovakPNovakAŠabovićMKozakM. Prophylactic dose of dalteparin in pregnant women with history of venous thromboembolisms and/or thrombophilia: real-world data. Angiology. 2023;74:783-789.
2.
MwansaHZghouziMBarnesGD. Unprovoked venous thromboembolism: the search for the cause. Med Clin North Am. 2023;107:861-882.
3.
DepietriLVeropalumboMRLeoneMCGhirarduzziA. Antiphospholipid syndrome: state of the art of clinical management. Cardiovasc Drugs Ther. 2023. doi: 10.1007/s10557-023-07496-3.
4.
RodziewiczMD'CruzDP. An update on the management of antiphospholipid syndrome. Ther Adv Musculoskelet Dis. 2020;12:1759720X20910855.
5.
HarteJVColeman-VaughanCCrowleyMPMykytivV. It's in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19. Crit Rev Clin Lab Sci. 2023;13:1-30.
6.
YuXHeL. Aspirin and heparin in the treatment of recurrent spontaneous abortion associated with antiphospholipid antibody syndrome: a systematic review and meta-analysis. Exp Ther Med. 2021;21:57.